Mabwell Biotech
Is dedicated to providing better and more accessible treatments for patients through cutting-edge research.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
* | N/A | $547m | IPO |
| Total Funding | 000k | ||
Shiyu Capital(exited)
Oriental Fortune Capital(exited)
Loyal Valley Capital(exited)
Founder H Fund(exited)
Haurong Rongde Asset Management(exited)
Huajin Capital(exited)
Sincere Capital(exited)
Ruihua Holdings(exited)
Shiyu Capital(exited)
| CNY | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 71 % | 361 % | 56 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (4242 %) | (3088 %) | (725 %) | (419 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (4743 %) | (3445 %) | (824 %) | (523 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 3836 % | 2736 % | 654 % | 392 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.